Computed Tomography Enterography and Inflammatory Bowel Disease

Author(s):  
J. G. Fletcher
2016 ◽  
Vol 22 (45) ◽  
pp. 10002 ◽  
Author(s):  
Natally Horvat ◽  
Camila Carlos Tavares ◽  
Adriana Ribas Andrade ◽  
Julia Campos Simões Cabral ◽  
Hilton Muniz Leao-Filho ◽  
...  

2018 ◽  
Vol 70 (5) ◽  
pp. 807-810 ◽  
Author(s):  
Jonathan Chan ◽  
Ismail Sari ◽  
David Salonen ◽  
Mark S. Silverberg ◽  
Nigil Haroon ◽  
...  

2012 ◽  
Vol 2012 ◽  
pp. 1-7 ◽  
Author(s):  
Patrick D. Mc Laughlin ◽  
Owen J. O’Connor ◽  
Siobhán B. O’Neill ◽  
Fergus Shanahan ◽  
Michael M. Maher

Patient awareness and concern regarding the potential health risks from ionizing radiation have peaked recently (Coakley et al., 2011) following widespread press and media coverage of the projected cancer risks from the increasing use of computed tomography (CT) (Berrington et al., 2007). The typical young and educated patient with inflammatory bowel disease (IBD) may in particular be conscious of his/her exposure to ionising radiation as a result of diagnostic imaging. Cumulative effective doses (CEDs) in patients with IBD have been reported as being high and are rising, primarily due to the more widespread and repeated use of CT (Desmond et al., 2008). Radiologists, technologists, and referring physicians have a responsibility to firstly counsel their patients accurately regarding the actual risks of ionizing radiation exposure; secondly to limit the use of those imaging modalities which involve ionising radiation to clinical situations where they are likely to change management; thirdly to ensure that a diagnostic quality imaging examination is acquired with lowest possible radiation exposure. In this paper, we synopsize available evidence related to radiation exposure and risk and we report advances in low-dose CT technology and examine the role for alternative imaging modalities such as ultrasonography or magnetic resonance imaging which avoid radiation exposure.


2011 ◽  
Vol 35 (2) ◽  
pp. 105-110 ◽  
Author(s):  
S.B. O’Neill ◽  
O.J. O’Connor ◽  
S.R. McWilliams ◽  
F. Shanahan ◽  
M.M. Maher

Author(s):  
Raj Shah ◽  
Abbinaya Elangovan ◽  
David W Jordan ◽  
Jeffry Katz ◽  
Gregory S Cooper

Abstract Background Patients with inflammatory bowel disease (IBD) frequently undergo multiple computed tomography (CT) examinations. With the widespread availability of magnetic resonance imaging (MRI), it is unclear whether the use of CTs in IBD has declined. We aimed to analyze the trends of CT and MRI use in a large cohort of IBD patients in a 10-year period. Methods We retrospectively analyzed adults ≥18 years of age using a de-identified database, IBM Explorys. Patients with ≥1 CT of the abdomen (± pelvis) or MRI of the abdomen (± pelvis) at least 30 days after the diagnosis of Crohn’s disease (CD) or ulcerative colitis (UC) were included. We examined the factors associated with patients undergoing multiple CTs (≥5 CTs of the abdomen) and performed a trend analysis from 2010 to 2019. Results Among 176 110 CD and 143 460 UC patients, those with ≥1 CT of the abdomen annually increased from 2010 to 2019 with mean annual percentage change of +3.6% for CD and +4.9% for UC. Similarly, annual percentage change for patients with ≥1 MRI (CD: +15.6%; UC: +22.8%) showed a rising trend. There was a 3.8% increase in CD patients receiving ≥5 CTs of the abdomen annually compared with a 2.4% increase among UC patients in the 10-year period. Age ≥50 years, men, African Americans, public insurance payors, body mass index ≥30kg/m2, and smoking history were associated with ≥5 CTs. Conclusions There is a considerable increase in the number of CT scans performed in IBD patients. Further studies can explore factors influencing the use of CT and MRI of the abdomen in IBD patients.


Sign in / Sign up

Export Citation Format

Share Document